title: Phase I and II trials of novel anti-cancer agents: endpoints, efficacy and existentialism. The Michel Clavel Lecture, held at the 10th NCI-EORTC Conference on New Drugs in Cancer Therapy, Amsterdam, 16-19 June 1998.
authors.affiliation: Investigational New Drug Program, NCIC Clinical Trials Group, Queen's University, Kingston, Ontario, Canada. eisenhae@ncic.ctg.queensu.ca
authors.forename: E A
authors.initials: EA
authors.lastname: Eisenhauer
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents